<code id='88DF99B1A4'></code><style id='88DF99B1A4'></style>
    • <acronym id='88DF99B1A4'></acronym>
      <center id='88DF99B1A4'><center id='88DF99B1A4'><tfoot id='88DF99B1A4'></tfoot></center><abbr id='88DF99B1A4'><dir id='88DF99B1A4'><tfoot id='88DF99B1A4'></tfoot><noframes id='88DF99B1A4'>

    • <optgroup id='88DF99B1A4'><strike id='88DF99B1A4'><sup id='88DF99B1A4'></sup></strike><code id='88DF99B1A4'></code></optgroup>
        1. <b id='88DF99B1A4'><label id='88DF99B1A4'><select id='88DF99B1A4'><dt id='88DF99B1A4'><span id='88DF99B1A4'></span></dt></select></label></b><u id='88DF99B1A4'></u>
          <i id='88DF99B1A4'><strike id='88DF99B1A4'><tt id='88DF99B1A4'><pre id='88DF99B1A4'></pre></tt></strike></i>

          Home / fashion / explore

          explore


          explore

          author:leisure time    Page View:1237
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In